Literature DB >> 21617801

Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches.

Angelo Gámez-Pozo1, Iker Sánchez-Navarro, Enrique Calvo, Esther Díaz, María Miguel-Martín, Rocío López, Teresa Agulló, Emilio Camafeita, Enrique Espinosa, Juan Antonio López, Manuel Nistal, Juan Ángel Fresno Vara.   

Abstract

Protein phosphorylation affects most eukaryotic cellular processes and its deregulation is considered a hallmark of cancer and other diseases. Phosphoproteomics may enable monitoring of altered signaling pathways as a means of stratifying tumors and facilitating the discovery of new drugs. Unfortunately, the development of molecular tests for clinical use is constrained by the limited availability of fresh frozen, clinically annotated samples. Here we report phosphopeptide analysis in human archival formalin-fixed, paraffin-embedded (FFPE) cancer samples based on immobilized metal affinity chromatography followed by liquid chromatography coupled with tandem mass spectrometry and selected reaction monitoring techniques. Our results indicate the equivalence of detectable phosphorylation rates in archival FFPE and fresh frozen tissues. Moreover, we demonstrate the applicability of targeted assays for phosphopeptide analysis in clinical archival FFPE samples, using an experimental workflow suitable for processing and analyzing large sample series. This work paves the way for the application of shotgun and targeted phosphoproteomics approaches in clinically relevant studies using archival clinical samples.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617801     DOI: 10.1039/c1mb05113j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  13 in total

1.  Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.

Authors:  Carine Steiner; Jean-Christophe Tille; Jens Lamerz; Sabine Kux van Geijtenbeek; Thomas A McKee; Miro Venturi; Laura Rubbia-Brandt; Denis Hochstrasser; Paul Cutler; Pierre Lescuyer; Axel Ducret
Journal:  Mol Cell Proteomics       Date:  2015-07-06       Impact factor: 5.911

2.  Phosphosignature predicts dasatinib response in non-small cell lung cancer.

Authors:  Martin Klammer; Marc Kaminski; Alexandra Zedler; Felix Oppermann; Stephanie Blencke; Sandra Marx; Stefan Müller; Andreas Tebbe; Klaus Godl; Christoph Schaab
Journal:  Mol Cell Proteomics       Date:  2012-05-21       Impact factor: 5.911

3.  Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues.

Authors:  Jacob J Kennedy; Jeffrey R Whiteaker; Regine M Schoenherr; Ping Yan; Kimberly Allison; Melissa Shipley; Melissa Lerch; Andrew N Hoofnagle; Geoffrey Stuart Baird; Amanda G Paulovich
Journal:  J Proteome Res       Date:  2016-07-27       Impact factor: 4.466

Review 4.  Application of molecular technologies for phosphoproteomic analysis of clinical samples.

Authors:  M Pierobon; J Wulfkuhle; L Liotta; E Petricoin
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

Review 5.  Comparative evaluation of two methods for LC-MS/MS proteomic analysis of formalin fixed and paraffin embedded tissues.

Authors:  Katarina Davalieva; Sanja Kiprijanovska; Aleksandar Dimovski; Gorazd Rosoklija; Andrew J Dwork
Journal:  J Proteomics       Date:  2021-01-14       Impact factor: 4.044

Review 6.  Toward deciphering proteomes of formalin-fixed paraffin-embedded (FFPE) tissues.

Authors:  Sameh Magdeldin; Tadashi Yamamoto
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

Review 7.  Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues.

Authors:  Carine Steiner; Axel Ducret; Jean-Christophe Tille; Marlene Thomas; Thomas A McKee; Laura Rubbia-Brandt; Alexander Scherl; Pierre Lescuyer; Paul Cutler
Journal:  Proteomics       Date:  2014-03       Impact factor: 3.984

Review 8.  Phosphoproteomics and lung cancer research.

Authors:  Elena López; William C S Cho
Journal:  Int J Mol Sci       Date:  2012-09-26       Impact factor: 5.923

9.  Colorectal cancer risk genes are functionally enriched in regulatory pathways.

Authors:  Xi Lu; Mingming Cao; Su Han; Youlin Yang; Jin Zhou
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

10.  Functional proteomics outlines the complexity of breast cancer molecular subtypes.

Authors:  Angelo Gámez-Pozo; Lucía Trilla-Fuertes; Julia Berges-Soria; Nathalie Selevsek; Rocío López-Vacas; Mariana Díaz-Almirón; Paolo Nanni; Jorge M Arevalillo; Hilario Navarro; Jonas Grossmann; Francisco Gayá Moreno; Rubén Gómez Rioja; Guillermo Prado-Vázquez; Andrea Zapater-Moros; Paloma Main; Jaime Feliú; Purificación Martínez Del Prado; Pilar Zamora; Eva Ciruelos; Enrique Espinosa; Juan Ángel Fresno Vara
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.